Facebook Linkedin RSS Twitter Youtube
Home 2024

Drug discovery

Qubit Number to Simulate Molecules Reportedly Reduced by the Sorbonne and Qubit Pharmaceuticals
Artificial Intelligence

Qubit Number to Simulate Molecules Reportedly Reduced by the Sorbonne and Qubit Pharmaceuticals

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs
Drug Discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

Navigating the Organ-on-Chip Landscape: Latest Regulatory Insights and the Path to Widespread Adoption
Multimedia

Navigating the Organ-on-Chip Landscape: Latest Regulatory Insights and the Path to Widespread Adoption

Creating Consistency and Confidence for Biopharma Companies
Bioprocessing

Creating Consistency and Confidence for Biopharma Companies

Like LEGOs, bit.bio’s CNS Tool Kit Allows Brain Exploration Piece by Piece
Drug Discovery

Like LEGOs, bit.bio’s CNS Tool Kit Allows Brain Exploration Piece by Piece

StockWatch: Chinese Biotechs Targeted by BIOSECURE Act Rise after House Committee Setback
Drug Discovery

StockWatch: Chinese Biotechs Targeted by BIOSECURE Act Rise after House Committee Setback

Shionogi, Qpex to Open Antimicrobial R&D Lab in San Diego
GEN Edge

Shionogi, Qpex to Open Antimicrobial R&D Lab in San Diego

AI Isn’t the Magic Bullet to Simplify Drug Discovery
Artificial Intelligence

AI Isn’t the Magic Bullet to Simplify Drug Discovery

Evolving Trends in Pharmaceuticals
Drug Discovery

Evolving Trends in Pharmaceuticals

123...515Page 1 of 515
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.